Epidemiological characteristics of mumps among people aged 0-14 in Jiangxi Province, 2015-2022
10.3760/cma.j.cn112338-20230805-00056
- VernacularTitle:江西省2015-2022年0~14岁人群流行性腮腺炎流行特征分析
- Author:
Yuqin ZHAO
1
;
Jing WU
;
Hui WU
;
Shicheng GUO
Author Information
1. 江西省疾病预防控制中心免疫规划所，南昌 330029
- Keywords:
Mumps;
Epidemic characteristics;
Containing mumps vaccine
- From:
Chinese Journal of Epidemiology
2024;45(2):225-229
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the epidemic characteristics of mumps in people aged 0-14 years in Jiangxi Province and the vaccination situation of mumps-containing vaccines (including mumps vaccines) from 2015 to 2022 to provide a scientific basis for the prevention and control of mumps epidemic in Jiangxi Province.Methods:The mumps epidemic situation and mumps vaccination data in Jiangxi Province from 2015 to 2022 were obtained from Chinese Disease Prevention and Control Information System and Jiangxi Immunization Program Information System and were analyzed using descriptive epidemiological methods. The chi-square test, cluster analysis, and Cochran-Armitage trend test were used for statistical analysis.Results:From 2015 to 2022, a total of 40 734 cases of mumps were reported in people aged 0-14 in Jiangxi Province, with an annual average reported incidence rate of 53.69/100 000, and the peak of incidence occurred in aged 6-7 years group, and the reported incidence rate was 86.43/100 000. The high incidence seasons in 2015-2019 were summer and winter, and there was no significant high incidence season in 2020-2022. Mumps outbreaks mainly occurred in Shangrao, Ganzhou, and Ji'an, and the outbreak sites were mainly reported primary schools. From 2015 to 2019, the 1-year group was the primary age group for vaccination against mumps, while from 2020 to 2021, it was 0 and 1-year groups.Conclusions:From 2015 to 2022, the incidence of mumps in the population aged 0-14 in Jiangxi Province showed a downward trend, and the peak of incidence occurred in age group 6-7 years. It is suggested to continue to strengthen the coverage rate of 2 doses of mumps vaccination for school-age children and, simultaneously, strengthen the monitoring and prevention of mumps in key places to avoid outbreaks.
